Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Cancer Pain 3 Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Opioid-Related Disorders 1 Neuralgia 1 Mucositis 1 Lymphoma, Follicular 1 Chronic Pain 1

Interventions

Pregabalin 5 Lidocaine 4 Surveys and Questionnaires 3 Bupivacaine 3 ziconotide 2 Transcranial Magnetic Stimulation 2 Oxycodone 2 Gabapentin 2 Capsaicin 2 Amitriptyline 2 onabotulinum toxin A 1 nabiximols 1 Yoga 1 Vitamin B 6 1 Vitamin B 12 1 Vinorelbine 1 Vincristine 1 Transcutaneous Electric Nerve Stimulation 1 Thalidomide 1 Telmisartan 1 Tapentadol 1 Spinal Cord Stimulation 1 Sodium Chloride 1 Saline Solution 1 Radiofrequency Ablation 1 Plastic Surgery Procedures 1 Paclitaxel 1 Oxaliplatin 1 Morphine 1 Methadone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuralgia × Buprenorphine × Clear all

NCT01946555 2016-04-14

RER

Mario Negri Institute for Pharmacological Research

Cancer Pain, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡